v3.25.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net income $ 397 $ 943 $ 386 $ 1,167  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation     388 372  
Amortization 53 52 104 106  
Amortization of deferred debt issuance costs     5 4  
Restructuring expense, net of cash paid     2 (34)  
Deferred income taxes     306 31  
Pension and other postretirement benefit expenses     23 23  
Loss from equity method investments, net of dividends received     29 110  
Loss on extinguishment of debt 0 0 3 0  
Loss on sale of assets     (4) 1  
Share-based compensation     71 57  
Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee (46) (641) (46) (641) $ (641)
Changes in operating assets and liabilities:          
Accounts receivable, net     (456) (46)  
Inventories     (155) (5)  
Other assets     (112) (30)  
Accounts payable     242 (110)  
Accrued and other long-term liabilities     (18) (83)  
Other, net     24 (22)  
Pension contributions     (9) (13)  
Net cash provided by operating activities     783 887  
Cash flows from investing activities:          
Capital expenditures     (346) (491)  
Proceeds from sale of property     2 2  
Proceeds from business divestitures, net of cash sold     4 0  
Proceeds from sale of technology investments     1 0  
Proceeds from the sale of equity method investment     164 448  
Purchase of short-term investments     0 (748)  
Cost of technology investments     (42) (40)  
Settlement of derivatives     5 0  
Net cash used in investing activities     (212) (829)  
Cash flows from financing activities:          
Net proceeds (repayments) under other short-term debt agreements     (458) (11)  
Net proceeds (repayments of) under term loans     (250) 0  
Proceeds from issuance of senior and junior notes, net of issuance costs     0 798  
Fees related to modification of debt agreements     (5) 0  
Repurchase of ordinary shares     0 (1,030)  
Taxes withheld and paid on employees' restricted share awards     (19) (21)  
Net cash used in by financing activities     (732) (264)  
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash     36 (25)  
(Decrease) increase in cash, cash equivalents and restricted cash     (125) (231)  
Cash, cash equivalents and restricted cash at beginning of period     1,574 1,640 1,640
Cash, cash equivalents and restricted cash at end of period $ 1,449 $ 1,409 1,449 1,409 $ 1,574
Capital expenditures included in accounts payable     $ 149 $ 167